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Abstract 
Introduction: Autism Spectrum Disorders (ASD) are behaviourally defined syndromes where 
the etiology and pathophysiology are not very well understood. If the child has been diagnosed 
with autism, parents already face special behavioural challenges. What makes ASD even more 
difficult, are the many other medical health issues that often arise in this population. 
The purpose of this article is to summarise the latest understanding of autism’s commonly 
associated physical and mental health conditions. 
Methods: An analysis of relevant literature, sources from the internet and published literature, 
personal experience and observations of the author. 
Recent findings: Autism is a disorder of the whole body. It is often in co-morbidity with: 
epilepsy, gastrointestinal disorders, neuro-inflammation and immunological disorders, asthma, 
eczema, sleep disturbances, eating and feeding disorders, food allergies, attention deficit and 
hyperactivity disorder (ADHD), headaches, anxiety disorders, bipolar disorder, depression, 
schizophrenia, obsessive-compulsive disorder, Fragile X syndrome, intellectual disability, 
nonverbal learning disorder, motor clumsiness, Tourette syndrome, sensory problems, tuberous 
sclerosis, oxidative stress, acquired mitochondrial dysfunction and metabolic abnormalities. 
Many of the issues outlined here can overlap each other. 
Conclusions: Improved understanding of the underlying pathology of ASD and associated 
conditions, and the development of a common purpose across multiple treating sites, can 
improve the consistent and coordinated healthcare of children with autism. There is need for 
the development of improved strategies for delivering effective health education and healthcare 
to this large population. Improving the ability of these persons to lead relatively independent 
lives has a great economic impact. 
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Introduction 
Autism Spectrum Disorders (ASD) are a 
heterogeneous group of complex 
neurodevelopmental conditions apparent in early 
childhood, characterised by persistent deficits in 
social communication and social interaction and 
restricted, repetitive patterns of behaviour, 
interests or activities (APA, 2013). Autism is not 
a disease, but it is a disorder which affects the 
immature, developing brain. It is obvious, that 
for many people, autism is a whole-body 
disorder. Its frequent co-morbidities include 
seizures, gastrointestinal disorders, sleep 
disturbances, eating and feeding challenges, 
attention deficit and hyperactivity disorder 
(ADHD), anxiety, depression, schizophrenia 
and bipolar disorder (Croen, 2015). Various 
markers of abnormal brain development (e.g. 
minor and major congenital anomalies) and risk 
factors for brain damage (e.g. pregnancy and 
birth complications) were also described in the 
literature. Parallel developments in medical 
diagnostics have also lead to improvements in 
the detection and diagnosis of medical 
conditions, so the prevalence of these conditions 
in individuals with ASD has also increased 
(Bolton, 2009). Genetic research is delving into 
the biological causes of autism-associated health 
conditions. This is part of a new avenue of autism 
research aimed at identifying the many 
biological subtypes of autism and developing 
personalised treatments and supports (Autism 
Speaks, 2017). 
The prevalence of ASD has been rising as the 
definition has evolved and awareness has 
increased. The most recent estimate suggests 
that 1 in 68 children in the United States are 
on the autism spectrum and that number 
increases in boys to 1 in 42 (CDC, 2016). To 
date, however, very little is known about 
ASD in adults, including their health status 
and healthcare needs (Mandell, 2013). 
Autism is relatively difficult to diagnose 
especially in developing countries. In the 
Republic of Macedonia, no services exist for 
adults with ASD. Based on the incidence of 
autism, there is an increased likelihood that 
healthcare providers will have children with 
autism in their practice. Current research 
estimates that a full-time pediatrician will 
have at least 20 to 25 patients on the autism 
spectrum (Carbone, 2013). 
Comorbid conditions may be markers for 
underlying pathophysiology and request a more 
varied treatment approach. Developmental, 
psychiatric, and neurologic disorders frequently 
co-occur in children with autism spectrum 
disorders and may have a significant impact on 
the identification, treatment needs, functional 
status, and progress of children with ASD 
(Gillberg & Billstedt, 2000). 
In one study which examines the prevalence of 
co-occurring conditions across multiple organ 
systems among a large sample of adults with 
ASD, Kohane et al. reported a higher prevalence 
of epilepsy, schizophrenia, inflammatory bowel 
disease, central nervous system (CNS)/cranial 
anomalies, diabetes mellitus type I, muscular 
dystrophy, and sleep disorders among autism 
cases compared to controls. This study 
population was restricted to young adults <35 
years of age. They found: 19.44% of ASD 
patients had epilepsy as compared to 2.19% in 
the overall hospital population, 2.43% of ASD 
with schizophrenia vs. 0.24% in the hospital 
population, inflammatory bowel disease (IBD) 
0.83% vs. 0.54%, bowel disorders (without IBD) 
11.74% vs. 4.5%, CNS/cranial anomalies 
12.45% vs. 1.19%, diabetes mellitus type I 
(DM1) 0.79% vs. 0.34%, muscular dystrophy 
0.47% vs 0.05%, sleep disorders 1.12% vs. 
0.14% (Kohane et al., 2012). 
The functional status of adults with ASD also 
remains poorly understood. In general, adaptive 
functioning in adults with neurodevelopmental 
disorders declines with advancing age in 
different ways from the general population, but 
this has not been examined in adults with ASD 
(Sullivan et al., 2011). Many adults with ASD 
develop new skills with age that allow them to 
thrive independently throughout life. Others 
require more supportive environments. 
Examining functional status is critical towards 
improving adaptive functioning and supporting 
independence for different cohorts of adults with 
ASD. Kogan et al. found that children with ASD 
had more difficulties accessing necessary care 
and had more unmet needs than other children 
with special healthcare needs. They also noted 
greater problems related to employment and 
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family financial concerns. The documented 
increase in healthcare expenses, gaps in 
treatment, and effects on family well-being call 
for more attention to the major medical concerns 
of children with ASD (Kogan et al., 2008). 
The purpose of this article is to summarise the 
latest understanding of autism’s commonly 
associated physical and mental health conditions. 
 
Methods 
A search of the two electronic data bases 
PubMed and Google Scholar was performed in 
order to identify published papers from the field 
of health condition and autism from September 
10th until October 12th 2018. The following 
keyword descriptors were used in combination: 
“health condition” and “autism”, or “medical 
condition” and “autism”, or “co-morbid 
disorders” and “autism”. The search was 
systematically conducted on journal articles in 
academic peer-reviewed journals and was not 
limited by year. A total number of 94 articles 
were selected for analysis from which 33 were in 
the Google Scholar database and 61 were in the 
PubMed database. From this 47 articles (50%) 
have been cited as relevant literature in this paper. 
The majority of the articles focus on medical 
conditions which are associated with ASD. 
 
Recent findings 
Improved awareness of concurrent medical 
conditions associated with autism can increase 
the medical professional’s index of suspicion 
when evaluating a child with autism (Celia, 
Freysteinson, & Frye, 2016). 
Medical conditions in autism can be divided into 
two categories such as: general and specific. The 
category general consists of disorders that do not 
have specific cause (intellectual disability and 
epilepsy). The category specific consists of 
distinct conditions such as: Fragile X syndrome, 
tuberous sclerosis, Down syndrome, etc. 
(Ghaziuddin, 2018). In the following text are 
descriptions of several examples of comorbid 
medical conditions that can be easily 
misdiagnosed in people with autism. 
 
1. Somatic comorbidities 
1.1. Autism and Epilepsy 
Epilepsy is one of the most common medical 
conditions associated with ASD. Epilepsy can 
begin at any point in the lifetime of someone 
with ASD but typically signs will show up by 
adolescence.  
Epilepsy affects a 5% to 46% of people who 
have autism, compared to an estimated 1 to 2% 
of the general population (Spence and Schneider, 
2009). In one of our previous studies, we found 
that convulsions as a symptom presented in 14% 
of 102 subjects with ASD (Trajkovski, 2014). 
The autism-epilepsy overlap appears to be most 
common among people who also have 
intellectual disability (Autism Speaks, 2017). 
Intellectual disability with challenges in 
everyday function affects an estimated 32% of 
those who have autism (Christensen, et al., 2016). 
While there are still not enough studies to 
conclusively determine why seizures are so 
common, scientists have found some evidence to 
support various scenarios. The risk for epilepsy 
appears to be higher in those children who 
experienced a regression of language skills 
before the age of three. The largest group at risk 
for seizure disorders appears to be those 
individuals diagnosed with intellectual disability 
in addition to ASD. Seizures appear to be more 
common in children who have used 
antipsychotic medications as part of their ASD 
treatment (Besag, 2018). 
Seizures can begin at any age, though research 
has identified two peaks in onset among children 
with autism in the preschool years and again in 
adolescence. Characteristic symptoms include: 
unexplained staring spells, stiffening of muscles, 
and involuntary jerking of limbs. Other less-
specific symptoms can include: sleepiness or 
sleep disturbances, marked and unexplained 
irritability or aggressiveness, and regression in 
normal development.  
Epilepsy in autism is treated by combinations of 
medications and educational and social 
interventions. Treatment with medications, such 
as anti-epileptic drugs, has often been associated 
with improvement in behaviour and language in 
this population (Frye et al., 2010). Referral to a 
child neurologist who has experience with 
children with autism would be appropriate. 
Though diet has not been shown as a factor 
causing seizures, some doctors have used a 
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ketogenic diet to significantly reduce and even 
eliminate seizures. This diet consists of 
increasing fat intake to four times the intake of 
carbs and proteins. Doctors still aren’t sure why 
this works but according to the Epilepsy 
Foundation, up to 2/3 of patients have found 
some success with the diet (Autism Speaks, 
2017). 
 
1.2. Sleep disorders 
Children with ASD have a significantly high rate 
of sleep disorders. It has been reported that up to 
80% have some issue with sleep. The two most 
common problems are difficulty falling asleep 
and waking up repeatedly.  Some children with 
ASD seem programmed to wake up early 
regardless of what time they go to sleep 
(Krakowiak et al., 2008). Sleep disorders are a 
common occurrence in the child with autism, 
compared to the non-autistic population. 
Individuals with autism may wake up during the 
night several times a week and stay awake for 
extensive periods of time (Bauman, 2010).  
Many things can impact a child’s ability to sleep. 
One common thread is that children with ASD 
often have greater anxiety and/or depression than 
other children. These feelings can cause a child 
to lay awake worrying, making it difficult for 
them to turn off their brain and fall asleep. If the 
child has a gastrointestinal disorder in addition to 
ASD, this can also be a factor to their ability to 
stay asleep throughout the night. Some sleeping 
problems can be attributed to behavioural 
problems in which the child hasn’t adjusted to 
limits being set. Any medications that a child 
may be taking can affect how they sleep. 
Regardless of the reason or theory for sleep 
disorders, it is critical that children on the autism 
spectrum get enough sleep. Lack of sleep can cause 
difficulties with attention, training, behaviours, or 
functioning during normal daytime hours, and can 
interfere with learning (Malow et al., 2012). 
Although there are many reported sleep problems, 
difficulties with obtaining proper 
polysomnographic studies in this population have 
resulted in fewer studies using objective measures 
to define the sleep disorder. Studies using these 
methods frequently find sleep abnormalities, 
confirming what is commonly reported by parents 
(Coury et al., 2009). 
There are extremely limited data on circadian 
dysregulation in toddlers and preschoolers with 
ASD, derived from a small number of 
participants. Existing findings suggest that very 
young ASD children suffer from significant 
disturbances in sleep circadian rhythmicity, 
however these accounts are entirely based on 
parental reports and have not yet been 
corroborated by more objective measures of the 
sleep-wake cycle. ASD preschoolers appear 
vulnerable to circadian dysregulation at the level 
of hormone secretion, however it seems that 
circadian misalignment becomes more evident 
in older children. ASD research is growingly 
focusing on early pathophysiological and 
behavioural markers of the disorder from fetal 
life to toddlerhood. In this context, there is strong 
evidence that melatonin abnormalities during 
pregnancy and early regulatory problems during 
infancy may lead to increased ASD risk, 
suggesting that circadian abnormalities may be 
causally associated with ASD-specific 
disturbances in neurogenesis and synaptogenesis 
(Karaivazoglou, & Assimakopoulos, 2018).  
Sleep disorders can affect the entire family but 
can be especially disruptive to the child, causing 
additional behavioural issues. Parents can 
establish routines to promote optimal sleeping 
conditions.  Some common practices include: 
keeping the bedroom dark and cool, keeping the 
waking and sleeping schedule consistent – even 
on weekends, not allowing children to have 
caffeine or coca cola, to establish a bedtime 
routine and stick to it and to make sure children 
get exercise each day. 
Melatonin, a pineal gland secretion that responds 
to darkness and promotes sleep in humans, is 
viewed by many as a natural and well tolerated 
treatment for sleep latency problems, where 
delayed or reduced melatonin release may be 
present. Several studies have reported on the use 
of melatonin in treating insomnia in children 
with developmental problems, with 
improvement in the majority of patients 
(Andersen et al. 2008, Johnson and Mallow, 
2008). It has also shown to be effective in adults 
with autism and chronic sleep problems, most 
frequently sleep latency concerns (Galli-
Carminati, Deriaz, and Bertschy, 2009). 
Melatonin is possibly safe when taken by mouth 
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as a single dose. It is possibly unsafe when taken 
by mouth or injected into the body in multiple 
doses in the short-term. Because of its effects on 
other hormones, melatonin might interfere with 
development during adolescence. Melatonin 
might make bleeding worse in people with 
bleeding disorders and might make symptoms of 
depression worse. It also might increase blood 
sugar in people with diabetes. Melatonin can 
raise blood pressure in people who are taking 
certain medications to control blood pressure.  
Using melatonin might increase the risk of 
having a seizure. 
 
1.3. Gastrointestinal disorders 
The most common gastrointestinal disorders 
which are connected with ASD are chronic 
diarrhoea and constipation. Other GI issues 
include frequent abdominal pain, gaseousness 
and painful stooling. Chronic GI issues with 
increased severity of autism’s behavioural 
symptoms – including repetitive behaviours, 
social withdrawal, hyperactivity and irritability. 
The association between GI issues and these 
autism symptoms may be particularly strong 
among nonverbal persons who have difficulty 
communicating pain and distress (Autism 
Speaks, 2017). Researchers have still not been 
able to clearly define why these children are 
more susceptible to GI problems but some 
studies suggest dietary allergies may play a role 
in some cases. Some children have been found 
to fare better when removing dairy and gluten 
from their diets. Others do better when processed 
foods with dyes are eliminated and others have 
added probiotics to their diet to offset symptoms. 
Some food elimination diets, such as gluten-
free/casein-free, have gained popularity in the 
autistic population and have also shown some 
improvement with GI symptoms. Current 
literature does not support this as a first-line 
intervention (Cash, 2011) but suggests these 
diets may be more effective on a case-by-case 
basis. Food elimination diets may alleviate GI 
symptoms by removing an unknown allergen or 
item that is not well-tolerated. Theories suggest 
ingesting irritant foods causes inflammation in 
the gut lining that causes the membranes to leak, 
releasing particles into the body outside the GI 
tract (Malow et al., 2012). 
Children suffering from GI problems may not 
exhibit typical symptoms so in some cases 
parents may not even know there is a problem. 
Some behaviours that can indicate a problem 
may include: coughing excessively, refusing to 
swallow food or difficulty swallowing, hitting 
self in jaw or fisting the jaw, chewing 
excessively, chewing on clothes, chin tapping, 
sleep problems, eating to relieve symptoms and 
unexplained changes in behaviour. 
Treatment depends on identification of the 
underlying GI issue. Some treatments 
considered may be food elimination trials, as 
well as allergy testing, to look for possible food 
sensitivities. Other treatments follow the 
standard care for issues such as GERD, 
constipation or diarrhoea (Buie et al., 2010). If a 
GI issue is suspected and standard treatments 
have not shown improvement, referral to a 
gastroenterologist who has experience with 
children with autism is recommended. 
One research into potential genetic causes for 
autism spectrum disorders has indicated a role 
for the autism spectrum disorder MET promoter 
variant rs1858830 in individuals with co-
occurring ASD and gastrointestinal conditions, 
suggesting that there are new opportunities for 
research on this relationship (Campbell, 2009). 
 
1.4. Feeding disorders 
Children with sensory issues due to autism may 
be at risk for feeding disorders including 
difficulty eating or swallowing food based on the 
smell, texture or colour. These children tend to 
be picky eaters and may even throw tantrums 
when asked to eat certain foods. The term 
“feeding disorder” describes problems with 
eating enough or the right type of food. Among 
children with autism, this often involves eating 
only a few types of foods, eating only certain 
textures or colours of food, and/or disruptive 
mealtime behaviour. These issues have many 
causes, including sensory aversions, anxiety (e.g. 
after an incidence of choking, gagging or 
vomiting) and rigidity (aversion to change). 
Many children with autism also have motor 
issues that involve difficulty with chewing and 
swallowing. Others have digestion problems 
such as slow stomach emptying (Autism Speaks, 
2017). One review of diagnostic records found 
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that an estimated 70 percent of children on the 
autism spectrum have feeding and/or eating 
problems and 36 percent of these had problems 
classified as “severe” (Romero et al., 2016). 
Chronic overeating is a common issue among 
both children and adults on the autism spectrum. 
Some people with autism have poor sensitivity 
to internal cues such as feeling full. Autism-
related aversions to strong flavours, textures and 
smells can lead to overconsumption of high-
calorie, low-nutrient foods. In addition, increased 
appetite is a common and serious side effect of 
the only FDA-approved medicines for autism-
associated challenging behaviour (agitation) – 
risperidone and aripiprazole (Scahill, 2016). The 
result is a high incidence of obesity – often 
combined with nutritional deficiencies – in both 
children and adults on the autism spectrum 
(Croen et al., 2015). 
Pica, the dangerous habit of eating nonfood 
items, is another feeding disorder long associated 
with autism. Anecdotally, pica appears to be 
concentrated among those whose autism is 
complicated by intellectual disability. It can 
include swallowing sharp objects such as nails, 
broken glass and pins, as well as poisonous 
substances such as paint chips and swimming 
pool chlorine tablets. Pica can place tremendous 
stress on caregivers by demanding their constant 
vigilance (Call et al., 2015). Parents dealing with 
these picky eaters are encouraged to offer 
choices while still having their child stick to the 
rules. Children should know that they have to eat 
one vegetable at dinner, but allow them to 
choose which one. It is also important to ensure 
that  achild isn’t avoiding a food because of an 
allergy. 
Avoidant Restrictive Food Intake Disorder 
(ARFID) is a new diagnosis in the DSM-5, and 
was previously referred to as “Selective Eating 
Disorder.” ARFID is similar to anorexia in that 
both disorders involve limitations in the amount 
and/or types of food consumed, but unlike 
anorexia, ARFID does not involve any distress 
about body shape or size, or fears of fatness. 
Although many children go through phases of 
picky or selective eating, a person with ARFID 
does not consume enough calories to grow and 
develop properly and, in adults, to maintain basic 
body function. In children, this results in stalled 
weight gain and vertical growth; in adults, it 
results in weight loss. ARFID can also result in 
problems at school or work, due to difficulties 
eating with others and extended times needed to 
eat. People with autism spectrum conditions are 
much more likely to develop ARFID, as are 
those with ADHD and intellectual disabilities 
(APA, 2013). 
 
1.5. Immune disorders 
A link between immune dysfunction and autism 
is further exemplified by a recent multi-genome 
analysis study, which found links between genes 
that predispose individuals to aberrant immune 
response to infections and risk of developing 
autism (Saxena et al., 2012), as well as two 
separate findings from large European birth 
cohorts, which both found perturbed immune 
responses and pro-inflammatory biomarkers in 
mothers and newborns who later develop autism 
(Abdallah et al., 2012; Brown et al., 2013). In 
autism, findings of chronic inflammation and 
immune dysregulation throughout the central 
nervous system are accompanied by serum 
findings, all pointing to widespread 
dysregulation of immune mechanisms. 
Individuals with autism often display immune 
abnormalities in the form of altered cytokine 
profiles, autoantibodies, changes in immune cell 
function and abnormal mast cell activation 
(Ashwood et al., 2011). 
Multiple allergies are common in children with 
autism, which supports the theory of an 
underlying immune system dysfunction in this 
population. The combination of food and 
environmental allergies often results in a domino 
effect on other body systems, evidenced by an 
inflammatory response with elevated serum 
cytokine and immunoglobulin E (IgE) levels. 
This is believed to affect the neurological system 
in individuals with autism. Reactions to common 
food or environmental allergies may vary from 
local to systemic and manifest in some children 
as behavioural or sleep issues (Autism 
Treatment Trust, 2013). Food allergies, like 
autism, have an underlying link to the immune 
system, which is why it’s possible that they may 
go hand in hand. In most cases the food allergies 
are not life-threatening for children with ASD 
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however certain foods may cause worsening of 
autistic symptoms.  
In the Macedonian study we examined specific 
IgA, IgG, and IgE antibodies to food antigens in 
35 participants with an autism spectrum disorder 
and 21 of their siblings. A statistically significant 
higher plasma concentration of IgA antibodies 
against alpha-lactalbumin, beta-lactoglobulin, 
casein, and gliadin were found in the children 
with a ASD. Plasma concentrations of IgG 
antibodies against alpha-lactalbumin, beta-
lactoglobulin, and casein in participants with 
ASD were significantly higher. IgE-specific 
antibodies (alpha-lactalbumin, beta-
lactoglobulin, casein, and gluten), as well as 
plasma concentration of total IgE, also were 
statistically significantly higher in the 
participants with ASD (Trajkovski et al., 2008). 
Both IgE and non-IgE mediated allergic 
reactions are increasingly recognised causative 
factors of anxiety and mood disorders. As well, 
these allergic reactions contribute to difficulty 
focusing, irritability, tics, daytime fatigue and 
sleep problems in both children and adults. In 
this survey it was found that approximately 16% 
of people with autism suffer from some kind of 
allergy to food, inhalants, etc. These findings 
indicate intestinal immunological disturbances 
and the need for gluten-casein free diets in this 
population (Trajkovski, 2013). Current 
treatment recommendations for allergies include 
avoiding the allergen (if known), testing for 
allergens, and evaluation by an allergy specialist. 
Antihistamines may be given to treat symptoms. 
The connection between autism and 
autoimmune disorders is gaining increasing 
support with a number of studies demonstrating 
a high incidence of autoimmune conditions in 
autism and an association between serum levels 
of various autoantibodies and severity of autistic 
symptoms (Chen et al., 2013). Autoantibodies to 
folate receptors for example are suspected to 
play a pathological role in some forms of 
idiopathic autism because of their negative 
effects on cerebral folate metabolism and well-
known involvement in other 
neurodevelopmental syndromes (Ramaekers et 
al., 2012). Family history of autoimmune 
diseases is significantly higher in autistic 
children than in the general population 
(McDougle and Carlezon, 2013). The 
combination of these findings has led many 
researchers and clinicians to suggest that 
autoimmune mechanisms could be a causative 
or contributing factor in at least a subset of 
individuals with autism. 
 
1.6. Autism and infections 
Vulnerability to infections is high in children and 
pregnant women. If infection occurs during 
pregnancy, the outcome depends on the immune 
status of the mother, the type and strain of the 
virus and the development stage of the fetus. 
Other factors, such as generic predisposition to 
autism may be important. Viral infections lead to 
the production of cytokines which can destroy 
neurons and damage fetal development. 
Depending on the virus and the site where the 
infection occurs, the cytokines could be 
produced directly in the brain or gain access to it 
through the blood-brain barrier. The most 
described viruses associated with the etiology of 
ASD are: herpes virus, cytomegalovirus, 
measles virus and rubella virus (Ghaziuddin, 
2018). In the Macedonian sample, the most 
prevalent medical condition was the acute 
infectious disease varicella in (34.5%) and 
measles in  (6.5%) of the people with autism 
(Trajkovski, 2013). 
 
1.7. Headaches  
One of the less common ASD symptoms is 
headaches. One reason may be because ASD 
can be associated with pain insensitivity.  This 
means that the child may just not feel the pain of 
a typical headache the same way a child without 
ASD would. Research has however indicated a 
link between migraines and ASD. One 
study found that children with sensory 
hyperactivity were more likely to experience 
migraines. Additionally those children with 
higher levels of anxiety are more likely to have 
migraines or cluster headaches than others 
(Sullivan et al., 2013). 
Children with ASD may also suffer from 
headaches if they are head bangers. Children 
who bang their heads may be doing so in an 
attempt to limit the pain signals that are being 
delivered to their brains. Inflammation caused by 
GI disorders can also cause headaches in a child. 
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Nutritional changes, behavioural therapies and 
other treatments to reduce anxiety can play a 
significant role in reducing these symptoms. 
 
1.8. Oxidative stress, mitochondrial 
dysfunction and metabolic abnormalities  
There is increasing evidence that mitochondrial 
dysfunction, perturbation in sulfur and amino 
acid metabolism, and high levels of oxidative 
stress are common in people affected by autism. 
Elevations in metabolic markers of oxidative 
stress as well as reduced levels of glutathione and 
other cellular antioxidants have been found in 
many areas of the body, including the brain and 
primary immune cells (Rose et al., 2012). 
Reactive oxygen species are destructive to cells 
and organs and elevated oxidative stress has been 
implicated in autoimmune, inflammatory, 
cardiovascular and neurodegene-rative diseases 
and cancer. A substantial percentage of autistic 
patients display markers of abnormal 
mitochondrial energy metabolism, such as 
elevated lactate, pyruvate, and alanine in blood, 
urine and/or cerebrospinal fluid, as well as serum 
carnitine deficiency (Frye et al., 2013). In the 
majority of cases this abnormal energy 
metabolism cannot be linked to specific inborn 
mitochondrial disease, or another primary inborn 
error of metabolism. It has therefore been 
suggested that in autism, abnormalities in 
mitochondrial function could be a downstream 
consequence of immune dysfunction (Rossignol 
and Frye, 2011). Insufficient mitochondrial 
energy production could both result from and 
contribute to cellular oxidative stress and chronic 
inflammation in autism. Raising antioxidant 
levels and/or metabolic precursors and 
supporting mitochondrial function have been 
proposed as treatment avenues. Routine 
metabolic screening and mitochondrial 
functional studies required for the diagnosis of 
mitochondrial disease are rarely performed for 
patients with autism, and the hypothesis of an 
etiological link between autism and 
mitochondrial dysfunction has therefore not 
been properly assessed. Mitochondrial 
dysfunction contributes to a number of language 
deficits, abnormal energy metabolism, chronic 
gastrointestinal problems, abnormalities in fatty 
acid oxidation, and increased oxidative stress. 
Nutritional supplementation to decrease 
oxidative stress along with factors to improve 
reduced glutathione, as well as hyperbaric 
oxygen therapy represent supported and 
rationale approaches. There is a need for reliable 
laboratory markers to detect abnormalities of 
mitochondrial function, which will then facilitate 
further clinical investigations in this subgroup of 
children with autism. 
 
2. Mental health comorbidities 
Epidemiological studies suggest that between 54 
and 70% of people with autism also have one or 
more other mental health conditions (Romero, 
2016). Like autism, ADHD, schizophrenia and 
bipolar disorder are neurodevelopmental 
conditions that appear to have roots in early brain 
development. Among people with autism, 
anxiety and depression may stem, at least in part, 
from autism-related impairments that increase 
daily stress and social isolation and decrease 
overall quality of life (Vasa et al., 2016). 
Untreated mental health conditions can 
profoundly worsen autism’s behavioural 
challenges. But because of overlapping 
symptoms, they can be particularly difficult to 
identify in someone who has autism (Sikora et al., 
2012). The social withdrawal associated with 
depression or schizophrenia, for example, can be 
difficult to distinguish from autism-related social 
impairments. In addition, many people with 
autism have difficulty identifying and expressing 
emotions and other internal feelings. Autism 
specialists have developed guidelines for 
diagnosing and treating some of the most 
common mental health conditions affecting 
children, and adults who have autism.  
 
2.1. Autism and ADHD 
Over the last decade, studies have suggested that 
between 30 and 61 percent of people with autism 
also have symptoms of ADHD (Romero, 2016). 
Symptoms of ADHD include a persistent pattern 
of inattention, hyperactivity and/or impulsivity 
that interferes with daily life, social development 
and learning. People with ADHD often fail to 
pay close attention to details and make careless 
mistakes at school or work. Often, they don’t 
appear to listen when spoken to, have trouble 
organizing tasks and fail to follow through on 
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instructions and assignments, especially those 
that require sustained attention. 
 
2.2. Autism and anxiety disorders 
Studies suggest that between 11 and 42% of 
people with autism struggle with one or more 
anxiety disorder (Vasa et al., 2016). These 
disorders include separation anxiety, panic 
disorder and phobias (extreme fear of certain 
noises, places). Most research on anxiety in 
autism has focused on children and adults who 
are verbal and have normal to high intelligence. 
Experts agree on the need for more studies 
involving the one-third of people with autism 
who are nonverbal or minimally verbal and/or 
have intellectual disability. Anxiety can trigger 
strong internal sensations of tension that include 
a racing heart, muscle tightness and stomach 
ache. In someone with autism, these feelings can 
prompt an increase in self-soothing, repetitive 
behaviours (flapping, rocking, spinning, etc.) 
and/or destructive or self-harming behaviours 
(shredding, clothing, head banging, etc.). 
Similarly, anxiety can be the underlying cause of 
new resistance to what had been an enjoyed 
activity (e.g. a trip to the beach, a birthday party, 
school, etc.) (Autism Speaks, 2017). 
 
2.3. Autism and depression 
Depression affects an estimated 7% children and 
26% of adults with autism (Croen, 2015). This 
compares to 2% of children and close to 7 
percent of adults in the general U.S. population. 
A recent report in the journal Pediatrics found 
that the rate of depression among children with 
autism rose dramatically with age, from just 
under 5 percent in grade-schoolers to just over 
20% in teenagers. It likewise rose with 
intellectual ability (IQ), as well as the presence of 
one or more of the medical conditions that 
commonly accompany autism – particularly 
seizures and gastrointestinal issues. That 
depression rates rise with age and intellectual 
ability suggests a painful awareness of autism’s 
social challenges and isolation, the researchers 
propose. That the rates increase with associated 
medical conditions may demonstrate their 
profound effect on quality of life. The authors 
called on healthcare professionals to consider 
screening for depression as a routine part of care 
for teens and adults who have autism – 
particularly those with normal to high IQ and 
those with additional medical issues. Signs and 
symptoms of depression include chronic feelings 
of sadness, hopelessness, worthlessness, 
emptiness and/or irritability. Also common: 
social isolation, moving or talking slowly, 
feeling restless, and having trouble sitting still or 
concentrating. At its most serious, depression 
can include frequent thoughts about death and/or 
suicide (Autism Speaks, 2017). 
 
2.4. Autism and schizophrenia 
In terms of symptoms, autism and schizophrenia 
both involve impairments in processing 
language and understanding other people’s 
thoughts and feelings. Clear differences include 
schizophrenia’s hallmark psychosis, which often 
involves hallucinations. In addition, autism’s 
core symptoms typically emerge between ages 1 
and 3 years; schizophrenia’s in early adulthood. 
Many clinicians have reported identifying 
autism at high rates in adults already diagnosed 
with schizophrenia and vice versa. Investigations 
looking at how commonly these two conditions 
occur together vary widely in their findings. 
Taken together, the studies found schizophrenia 
in 4 to 35% of adults who have autism and found 
autism in 4 to 60% of those who have 
schizophrenia. Many of the same gene 
changes known to increase risk of autism also 
increase the risk of schizophrenia (Autism 
Speaks, 2017). 
 
2.5. Autism and bipolar disorder 
Bipolar disorder is a mood disorder also known 
as “manic depression”. People with bipolar 
disorder tend to alternate between a frenzied state 
known as mania and episodes of depression. 
While some people experience only the manic 
episodes, most alternate between these two states 
and can show extreme irritability. Research 
shows that children and adults with autism are at 
increased risk for bipolar disorder. However, 
studies vary widely in estimating the prevalence 
of bipolar disorder among people with autism, 
ranging from 6 to 27%. Bipolar disorder affects 
around 4% of the general population. Some 
leading experts propose that bipolar disorder 
may be over-diagnosed in those who have 
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autism, due to overlapping symptoms such as 
hyperactivity, irritability and disturbed sleep. 
They caution mental health providers to tease 
apart the symptoms of true bipolar disorder from 
those of autism by looking at when the 
symptoms appeared and how long they lasted.  
The antipsychotics risperidone and aripiprazole 
can treat irritability in children with autism, 
though both tend to produce significant weight 
gain and diabetes risk (Autism Speaks, 2017).  
 
Conclusions 
Autism can affect the whole body. An increasing 
number of medical disorders are being identified 
in individuals with ASD and studies are starting 
to identify the conditions that probably play a 
causal role in etio-pathogenesis. People 
identified with autism spectrum disorders have 
high frequencies of one or more co-occurring 
non-ASD developmental, psychiatric, 
neurologic, metabolic, immune, gastrointestinal 
and possibly causative medical diagnoses. 
Seizures, disturbed sleep and painful 
gastrointestinal disorders are some of the health 
conditions commonly associated with autism. 
Autism is also frequently accompanied by 
mental health conditions including anxiety, 
depression, and ADHD. Medical conditions and 
consecutive pathological processes can 
negatively impact behaviour, socialisation, 
communication, cognitive function and sensory 
processing of individuals with autism. It is also 
becoming increasingly clear that the medical 
comorbidities that underlie autism are not 
stagnant or transient, but tend to be chronic and 
in many cases, if left unrecognised and untreated, 
progressive. Accurate diagnosis and treatment 
often results in improved level of functioning 
and decreased severity of symptoms. Healthcare 
providers should be aware of the medical 
conditions that occur with ASD. Children with 
autism do not have typical presentations for 
medical illnesses and that’s why careful 
assessment and attention should be paid to the 
subtlest differences that occur. 
Autism-associated health problems extend 
across the life span – from young children to 
senior citizens. A better understanding of the 
possible mechanisms leading to poorer health 
status will enable improved patient care and 
ultimately enhance the quality of life for people 
with autism spectrum disorders. Despite the 
prevalence of these health conditions, more 
systematic research is needed to understand their 
manifestation in people with ASD and the best 
practices for identifying and treating them. 
Specialists at autism care centres are working 
with patients and their families to improve the 
health and quality of life of all those with ASD 
by developing and disseminating evaluation and 
treatment guidelines for healthcare providers. 
Appropriate and individualised medical 
assessments must be carried out in all cases, 
including a documented clinical examination.  
Autism spectrum disorder usually occurs with 
medical or psychiatric health conditions. 
Treatment should address not only the 
symptoms of autism but also those of the 
associated comorbidities. 
 
Conflicts of interests 
The author declares no conflict of interests. 
 
References 
Abdallah, M., Mortensen, E., Greaves-Lord, K., 
et al. (2012). Neonatal levels of 
neurotrophic factors and risk of autism 
spectrum disorders. Acta Psychiatrica 
Scandinavica; 252: (1-2): 75-82. 
American Psychiatric Association (APA). 
(2013). Diagnostic and Statistical Manual 
of Mental Disorders. Washington, DC: 
APA. 
Andersen, I.M., Kaczmarska, J., McGrew, S.G., 
et al. (2008). Melatonin for insomnia in 
children with autism spectrum disorders. J 
Child Neurol; 23:482–485. 
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., 
et al. (2011). Elevated plasma cytokines in 
autism spectrum disorders provide 
evidence of immune dysfunction and are 
associated with impaired behavioral 
outcome. Brain, behavior, and immunity, 
25(1): 40–45. 
Autism Speaks (2017). Autism and Health: a 
special report by autism speaks. Available 
from url: 
https://www.autismspeaks.org/science-
news/autism-and-health-special-report-
autism-speaks. 
Trajkovski V. Health condition in persons with autism spectrum disorders 
__________________________________________________________________________________________ 
122                                                                                                                                                   https://jrtdd.com 
Autism Treatment Trust. (2013). Medical 
comorbidities in autism spectrum 
disorders. Available from url: 
http://www.autismtreatmenttrust.org/wp-
content/uploads/2013/03/Medical-
Comorbidities-in-Autism-Spectrum-
Disorders-20131.pdf. 
Bauman, M.L. (2010). Medical comorbidities in 
autism: Challenges to diagnosis and 
treatment. Neurotherapeutics, 7(3), 320-
327. doi:10.1016/j.nurt.2010.06. 001. 
Besag F. M. (2018). Epilepsy in patients with 
autism: links, risks and treatment 
challenges. Neuropsychiatr. Dis. 
Treat. 14 1–10. doi: 
10.2147/NDT.S120509. 
Brown, A., Sourander, A., Hinkka-Yli-Salomäki, 
S., et al. (2013). Elevated maternal C-
reactive protein and autism in a national 
birth cohort. Molecular Psychiatry; 2013 
Jan 22. doi: 10.1038/mp.2012.197. 
Buie, T., Campbell, D.B., Fuchs, G.J., Furuta, 
G.T., Levy, J., de Water, J.V., Lewis, J.D. 
(2010). Evaluation, diagnosis, and 
treatment of gastrointestinal disorders in 
individuals with ASD’s: A consensus 
report. Pediatrics, 125, S1-S18. 
doi:10.1542/peds.2009-1878C. 
Bolton, F.P. (2009). Medical conditions in 
autism spectrum disorders. J 
Neurodevelop Disord; 1:102–113. DOI 
10.1007/s11689-009-9021-z. 
Call, N.A., Simmons, C.A., Mevers, J.E.L. et al. 
(2015). J Autism Dev Disord; 45: 2105. 
https://doi.org/10.1007/s10803-015-
2375-z. 
Campbell, D.B., Buie, T.M., Winter, H., et al. 
(2009). Distinct genetic risk based on 
association of MET in families with co-
occurring autism and gastrointestinal 
conditions. Pediatrics; 123:1018–1024. 
Carbone, P.S. (2013). Moving from research to 
practice in the primary care of children 
with autism spectrum disorders. 
Academic Pediatrics, 13(5), 390-399. 
doi:10. 1016/j.acap.2013.04.003. 
Cash, J.C. (2011). Nasal guidelines: Allergic 
rhinitis. In J.C. Cash, & C.A. Glass (Eds.), 
Family practice guidelines (2nd ed., pp. 
93-100). New York, NY: Springer 
Publishing. 
Celia, T., Freysteinson, W.W., and Frye, E.R. 
(2016). Concurrent Medical Conditions in 
Autism Spectrum Disorders. Pediatric 
Nursing; 42(5): 230–234 
Centers for Disease Control and Prevention 
(CDC). (2016). Autism spectrum disorder 
(ASD): Data and statistics. Available 
from 
http://www.cdc.gov/ncbddd/autism/data.
html. 
Chen, M.H., Su, T.P., Chen, Y.S., et al. (2013). 
Comorbidity of allergic and autoimmune 
diseases in patients with autism spectrum 
disorder: A nationwide population-based 
study. Research in Autism Spectrum 
Disorders, 7: (2): 205-212. 
Christensen DL, Baio J, Van Naarden Braun K, 
et al. (2016). Prevalence and 
Characteristics of Autism Spectrum 
Disorder Among Children Aged 8 Years 
– Autism and Developmental Disabilities 
Monitoring Network, 11 Sites, United 
States, 2012. MMWR Surveill Summ. 
1;65(3):1-23. 
Coury, D., Jones, N.E., Klatka, K., Winklosky, 
B., Perrin, J.M. (2009). Healthcare for 
children with autism: the Autism 
Treatment Network. Curr Opin 
Pediatr 21(6): 828-32. doi: 
10.1097/MOP.0b013e328331eaaa. 
Croen, A.L., Zerbo, O., Qian, Y., Massolo, L.M., 
Rich, S., Sidney, S., Kripke, C. (2015). 
The health status of adults on the autism 
spectrum. Autism; 1-10. DOI: 
10.1177/1362361315577517. 
Galli-Carminati, G., Deriaz, N., Bertschy, G. 
(2009). Melatonin in treatment of chronic 
sleep disorders in adults with autism: a 
retrospective study. Swiss Med Wkly 
2009; 139:293–296. 
Ghaziuddin, M. (2018). Medical Aspects of 
Autism and Asperger Syndrome – A 
Guide for Parents and Professionals. 
Jessica Kingsley Publishers, London and 
Philadelphia. 
Frye, R.E., Butler, I., Strickland, D., Castillo, E., 
& Papanicolaou, A. (2010). Electro-
encephalogram discharges in atypical 
Medical Aspects of Disability 
______________________________________________________________ 
Journal for ReAttach Therapy and Developmental Diversities 2019 Feb 17; 1(2):112-124                                                  123 
cognitive development. Journal of Child 
Neurology, 25(5), 556-566. 
doi:10.1177/0883073809344743. 
Frye, R.E., Melnyk, S. and MacFabe, D.F. 
(2013). Unique acyl-carnitine profiles are 
potential biomarkers for acquired 
mitochondrial disease in autism spectrum 
disorder. Translational Psychiatry, 3: (1): 
e220. 
Gillberg, C., Billstedt, E. (2000). Autism and 
Asperger syndrome: coexistence with 
other clinical disorders. Acta Psychiatr 
Scand 102: 321–330. 
Johnson, K.P., Malow, B.A. (2008). Assessment 
and pharmacologic treatment of sleep 
disturbance in autism. Child Adolesc 
Psychiatr Clin N Am; 17:773–785. 
Karaivazoglou, K., Assimakopoulos, K. (2018). 
Circadian Dysregulation in Young 
Children with Autism Spectrum Disorder. 
J Sleep Med Disord 5(2): 1092. 
Kogan, M.D., Strickland, B.B., Blumberg, S.J., 
et al. (2008). Anational profile of the 
healthcare experiences and family impact 
of autism spectrum disorder among 
children in the United States, 2005–2006. 
Pediatrics; 122:e1149–e1158. 
Kohane IS, McMurry A, Weber G, et al. (2012) 
The co-morbidity burden of children and 
young adults with autism spectrum 
disorders. PLoS One 7(4): e33224. 
Krakowiak, P., Goodlin-Jones, B., Hertz-
Picciotto, I., Croen, L., Hansen, R. (2008). 
Sleep problems in children with autism 
spectrum disorders, developmental delays, 
and typical development: a population-
based study. J Sleep Res. 17(2): 197-206. 
doi: 10.1111/j.1365-2869.2008.00650.x. 
McDougle, C.J. and Carlezon, W.A. (2013). 
Neuroinflammation and Autism: Toward 
Mechanisms and Treatments. 
Neuropsychopharmacology, 38: (1): 
241–242. 
Malow, B., Adkins, K.W., McGrew, S.G., 
Wang, L., Goldman, S.E., Fawkes, D., & 
Burnette, C. (2012). Melatonin for sleep in 
children with autism: A controlled trial 
examining dose, tolerability and 
outcomes. Journal of Autism & 
Developmental Disorders, 42(8), 1729–
1737. doi:10.1007/s10803-011-1418-3. 
Mandell, D.S. (2013). Adults with autism-a new 
minority. Journal of General Internal 
Medicine 28(6): 751–752. 
Ramaekers, V., Sequeira, J.M. and Quadros, E.V. 
(2012). Clinical recognition and aspects of 
the cerebral folate deficiency syndromes. 
Clinical Chemistray Laboratory Medicine, 
Dec 20:1-15. doi: 10.1515/cclm-2012-
0543. 
Romero, M., Manuel Aguilar, J., Del-Rey-
Mejías, A., et al. (2016). Psychiatric 
comorbidities in autism spectrum 
disorder: A comparative study between 
DSM-IV-TR and DSM-5 diagnosis. 
International Journal of Clinical and 
Health Psychology; 16: 266–275. 
Rose, S., Melnyk, S., Pavliv, O., et al. (2012). 
Evidence of oxidative damage and 
inflammation associated with low 
glutathione redox status in the autism 
brain. Translational Psychiatry, 2: (7): 
e134. 
Rossignol, D. and Frye, R. (2011). 
Mitochondrial dysfunction in autism 
spectrum disorders: a systematic review 
and meta-analysis. Molecular Psychiatry, 
17: (3): 290–314. 
Saxena, V., Ramdas, S., Ochoa, C.R., et al. 
(2012). Structural, Genetic, and 
Functional Signatures of Disordered 
Neuro-Immunological Development in 
Autism Spectrum Disorder. PloS one; 7: 
(12): e48835. 
Scahill, L., Jeon, S., Boorin, S. J., McDougle, C. 
J., Aman, M. G., Dziura, J., McCracken, J. 
T., Caprio, S., Arnold, L. E., Nicol, G., 
Deng, Y., Challa, S. A., Vitiello, B. (2016). 
Weight Gain and Metabolic 
Consequences of Risperidone in Young 
Children With Autism Spectrum 
Disorder. Journal of the American 
Academy of Child and Adolescent 
Psychiatry, 55(5), 415–423. 
Sikora, D.M., Vora, P., Coury, D.L., Rosenberg, 
D. (2012). Attention-deficit/hyperactivity 
disorder symptoms, adaptive functioning 
and quality of life in children with autism 
Trajkovski V. Health condition in persons with autism spectrum disorders 
__________________________________________________________________________________________ 
124                                                                                                                                                   https://jrtdd.com 
spectrum disorder. Pediatrics;130:S91–
97. 
Spence, S.J., Schneider, M.T. (2009). The role of 
epilepsy and epileptiform EEGs in autism 
spectrum disorders. Pediatr Res; 65:599–
606. 
doi:10.1203/PDR.0b013e31819e7168. 
Sullivan, W.F., Berg, J.M., Bradley, E, et al. 
(2011). Primary care of adults with 
developmental disabilities: Canadian 
consensus guidelines. Can Fam 
Physician;57(5): 541–553. 
Sullivan, J. C., Miller, L. J., Nielsen, D. M., & 
Schoen, S. A. (2013). The presence of 
migraines and its association with sensory 
hyperreactivity and anxiety symptomato-
logy in children with autism spectrum 
disorder. Autism, 1362361313489377. 
Trajkovski V, Petlichkovski A, Efinska-
Mladenovska O, Trajkov D, Arsov T, 
Strezova A, Ajdinski Lj, Spiroski M. 2008, 
‘Higher Plasma Concentration of Food-
Specific Antibodies in Persons with 
Autistic Disorder in Comparison to Their 
Siblings’. Focus on Autism and Other 
Developmental Disabilities 23 (3): 176–
185. 
Trajkovski V. Co-morbid medical conditions in 
autism spectrum disorders. In: 
Chichevska Jovanova N, Dimitrova 
Radojichikj D, Jachova Z, editors. 
Proceedings of Fourth International 
Conference: Modern Aspects of Special 
Education and Rehabilitation of Persons 
with Disabilities, 2013 October 17-19; 
Ohrid: Faculty of Philosophy; c2014. 56–
69. 
Vasa, R.A., Mazurek, M.O., Mahajan, R., et al. 
(2016). Assessment and treatment of 
anxiety in youth with autism spectrum 
disorders. Pediatrics;137:S115–123. 
 
 
 
 
 
 
 
